research article
Bioequivalence Study of Fixed-Dose Combination of Remogliflozin Etabonate 100 mg/Vildagliptin 50 mg with Individual Components in Healthy Indian Male Subjects under Fed Conditions
Shashank Joshi, Jayshree Swain, Rahul Kodgule, Monika Tandon, Sagar Katare, Sachin Suryawanshi, Hanmant Barkate, Kiran Khaladkar
Journal of Diabetes and Treatmentresearch article
Efficacy and Safety of Fixed-dose Combination of Teneligliptin and Pioglitazone versus Respective Monotherapies in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Phase III Randomized Parallel Group Study
A Gopal Rao, Richa Giri, Sanjiv Maheshwari, Vibhuti Jadhao, Sachin Suryawanshi, Hanmant Barkate
Journal of Diabetes and Treatmentresearch article
A Randomized, Double-blind, Active-controlled Study of Remogliflozin Etabonate 100 mg plus Teneligliptin 10 mg Twice-daily versus Teneligliptin 20 mg Oncedaily as add-on to Metformin Monotherapy in Indian Diabetic Patients
Rahul Kodgule, Monika Tandon, Rajesh Gaikwad, Amol Pendse, Kiran Khaladkar, Manoj Kumar, Sumit Bhushan, Sachin Suryawanshi, Hanmant Barkate
Journal of Diabetes and Treatmentresearch article
Prevalence of the Coeliac Disease among Patients with Type 1 Diabetes Followed Up at the Endocrine Unit in the Lady Ridgeway Hospital for Children Colombo
Dilhara Senani Gamage,*, Shereen Ashkin, Navoda Atapattu,
Journal of Diabetes and Treatment